Literature DB >> 32578678

Role that anorexia and weight loss play in patients with stage IV lung cancer.

Juliana Pereira Franceschini1, Sergio Jamnik1, Ilka Lopes Santoro1.   

Abstract

OBJECTIVE: To evaluate the prevalence of anorexia and weight loss at diagnosis (pre-treatment), to identify the factors associated with pre-treatment weight loss, and to determine the prognostic role of anorexia and weight loss in the overall survival of patients with stage IV lung cancer.
METHODS: This was a retrospective observational cohort study. The patients were stratified by the presence/absence of anorexia and of pre-treatment weight loss, which generated a measure composed of four categories, which were the independent variables.
RESULTS: Among the 552 patients included in the study, anorexia and pre-treatment weight loss were present in 39.1% and 70.1%, respectively. After adjusting for age, male gender, and Karnofsky performance status, we found that anorexia and tumor size were significantly associated with pre-treatment weight loss. In a Cox multivariate analysis, adjusted for age, male gender and low Karnofsky performance status were found to be independent predictors of worse survival, as was concomitance of anorexia and weight loss.
CONCLUSIONS: Anorexia and pre-treatment weight loss appear to be relevant problems in the follow-up of patients with advanced (stage IV) lung cancer Specific interventions are of crucial importance in individualized treatment plans, even within the context of palliative care.

Entities:  

Year:  2020        PMID: 32578678     DOI: 10.36416/1806-3756/e20190420

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


  2 in total

1.  Worse Prognosis in the Symptomatic Patients With Lung Cancer - Czech Multicentric Study.

Authors:  Miloslav Marel; Zdenka Chladkova; Luis Fernando Casas Mendez; Ondrej Venclicek; Jana Skrickova; Ondej Fischer; Andrea Mullerova; Libor Havel; Zuzana Gyorfy; Michal Hrnciarik; Michal Jirousek; Jana Krejci; Daniel Krejci; Marcela Buresova; Jana Alahakoon; Michal Svoboda; Martin Svaton
Journal:  Cancer Diagn Progn       Date:  2022-03-03

2.  Challenging scenarios in the treatment of lung cancer.

Authors:  Ana Caroline Zimmer Gelatti; Vinicius Lorandi
Journal:  J Bras Pneumol       Date:  2020-09-07       Impact factor: 2.800

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.